Latest newsView all news
Expansion of the Pathology Range with RevMAb antibodies
January 16, 2015 - RevMAb Biosciences USA, Inc has developed a revolutionary monoclonal antibody generation method which allows development of monoclonal antibodies without generation of hybridoma.
Exclusive products from ESI BIO, now available
January 15, 2015 - Sanbio signed an exclusive contract with ESI BIO, division of BioTime Inc. The breakthrough stem cell technologies, light the path from research to clinic in order to help our customers with their goal of treating disease.